Drug Profile
Research programme: biologics - Navya Biologicals
Alternative Names: NAV 002; NAV 003; NAV 004; NAV 005; NAV 007; NAV 008; NAV 009; NAV 010; NAV 012; NAV 013Latest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Navya Biologicals
- Class Biological peptides; Biological proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Age-related macular degeneration; Autoimmune disorders; Cancer; Infertility; Inflammatory bowel diseases; Myocardial infarction; Renal failure; Unspecified
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for preclinical development in Autoimmune-disorders in India
- 28 Dec 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in India
- 28 Dec 2020 No recent reports of development identified for preclinical development in Renal-failure in India